Letters to the Editor

First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies

Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Department of Laboratory Medicine, Ghent University Hospital, Ghent
Cambridge University Hospitals NHS Foundation Trust, Cambridge
Department of Pediatrics, Semmelweis University, Budapest
Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, INSERM U1015, Université Paris-Saclay, Villejuif
Department of Pediatrics, Aalborg University Hospital, Aalborg
Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen
Pediatric Oncology and Hematology Department, Hospital Vall d'Hebrón, Barcelona
Sección de Oncohematología Pediátrica, Hospital Virgen de Arrixaca, Murcia
Pediatric Oncology and Hematology Department, Hospital Infantil Universitario Niño Jesús, Madrid
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research; Philadelphia, Pennsylvania, USA; University of Pennsylvania School of Medicine, Department of Pediatrics; Philadelphia, Pennsylvania
Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne
Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne
Department of Pediatrics, Semmelweis University, Budapest
Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen
Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent
University Hospital Robert Debré (APHP) and Université de Paris, Paris
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam
Haematologica Early view Apr 2, 2026 https://doi.org/10.3324/haematol.2025.300154